3D cell culture is a growing field in the biotechnology industry, with a market projected to reach US$ 1.2 Bn by 2022. 3D cell culture refers to the use of three-dimensional scaffolds or microenvironments to mimic the in vivo conditions of cells, allowing for more realistic and biologically relevant research and drug development.
The global revenue from the 3D cell culture market stands at US$ 1.2 Bn in 2022, with the global market expected to grow at a CAGR of 9.4% to reach a valuation of approximately US$ 3.1 Bn by the end of 2033.
| Market Size (2022) |
US$ 1.2 Bn |
| Projected Market Value (2033) |
US$ 3.1 Bn |
| Global Market Growth Rate (2023-2033) |
9.4% CAGR |
| Market Share of Top 5 Countries |
66.4% |
Request For Free Sample Report of “3D Cell Cultures Market”@ https://www.persistencemarketresearch.com/samples/3329
There are several types of 3D cell culture systems available, including hydrogels, spheroids, and organoids. These systems allow researchers to study cell behavior in a more complex and realistic environment, leading to a better understanding of cellular processes and diseases.
The increasing demand for personalized medicine and the need for more predictive and reliable drug development models are driving the growth of the 3D cell culture market. Additionally, the development of new technologies and materials for 3D cell culture, such as the use of graphene and other nanomaterials, is expected to further boost the market.
Companies
- (BICO GROUP AB) CELLINK
- Merck KGaA
- Allevi, Inc.
- TheWell Bioscience Inc.
- CollPlant Biotechnologies Ltd.
- UPM Biomedicals
- Brinter®
- Foldink
- Black Drop Biodrucker Gmb
- TissueLabs
Buy Full Report Now and Get Up to 20% Discount @ https://www.persistencemarketresearch.com/checkout/3329
The 3D cell culture market is segmented by product, application, and end user. The product segment includes scaffolds, microplates, bioreactors, and others. The application segment includes cancer research, tissue engineering, and drug discovery and development. The end user segment includes academic and research institutes, pharmaceutical and biotechnology companies, and contract research organizations.
Overall, the 3D cell culture market is expected to experience significant growth in the coming years, with increasing demand for more realistic and biologically relevant research and drug development models driving the market forward.
Competition Landscape
Manufacturers mostly use partnerships, launches, expansions, mergers, and acquisitions to boost sales across various geographies enhancing product portfolio via new product lines and R&D expenditures. Businesses are making significant R&D investments to diversify their product offerings and increase their global market presence, particularly to meet the changing demands of researchers.
Some key instances of development within the market include:
- Greiner Bio-One purchased the 3D cell culture technology assets from Nano3D Biosciences, Inc. in May 2018.
- Thermo Fisher Scientific, Inc. and Janssen signed a contract in March 2020 to jointly develop companion diagnostic for cancer treatment.
Request Customization @ https://www.persistencemarketresearch.com/request-customization/3329
Key Segments Covered in Global 3D Cell Culture Industry Research
Product:
- Scaffold Free 3D Cell Culture
- Scaffold Based 3D Cell Culture
- Hydrogel based 3D cell culture
- Polymeric Hard Material Based 3D cell Culture
Application:
- Drug Discovery
- Tissue Regeneration & Regenerative Medicines
- Cancer Research
- Stem Cell Technology
- Others
End User:
- Biotechnology and Pharmaceuticals Industries
- Academic Research Institutes
- Hospital Laboratories
- Contract Research Organization
For More Premium Insights, Check out the Link:
Cell Culture Media Market
Smart Inhalers Market
Hospital Acquired Infection Control Market
About Us
Persistence Market Research’s Expertise in Life Sciences and Transformational Health
Our expert team of industry analysts comprising management graduates, medical professionals, engineers, and project managers provides insights on emerging therapy areas, diagnostic tools, medical devices and components, reimbursement and market access, biotechnology, and life science research products and services to equip decision-makers with sound inputs and strategic recommendations. Click here to learn more about how we zero in on the critical aspects of this industry.
Contact Us:
Persistence Market Research
Japan
Persistence Market Research
1-2-1 Kinshi Arca Central Building 14/F Tokyo, 130-0013 Japan
Call 0800-222-1088
United States
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]
This Press Release has been written with the intention of providing accurate market information which will enable our readers to make informed strategic investment decisions. If you notice any problem with this content, please feel free to reach us on [email protected]